Legal Clash: AstraZeneca Fights to Overturn Louisiana’s Controversial 340B Law in Appeals Court
New Orleans, Louisiana — An attorney representing AstraZeneca argued before an appeals court this week for the invalidation of a state law concerning the 340B Drug Pricing Program. This legal dispute highlights a growing concern among pharmaceutical companies regarding the impact of similar legislation across the United States. The attorney contended that the Louisiana law significantly alters how drug pricing is managed, contending that it imposes restrictions that could disrupt the pharmaceutical industry’s operations. The 340B program is designed to enable healthcare providers serving high numbers of low-income patients to purchase drugs at reduced prices. … Read more